Awarded

Tafasitamab 200 mg Pó conc sol inj Fr IV

Name: Tafasitamab 200 mg Pó conc sol inj Fr IV
Creator: Unidade Local de Saúde de Coimbra, EPE
Published: 2026-10-26
License: https://ted.europa.eu/en/simap/legal-notice

Original language: Portuguese

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: Unidade Local de Saúde de Coimbra, EPE
Winners: Cencora 3Pl Portugal, S.A.
Contract value: €126,324
Bids received: 2
Published: 26 Oct 2026
Awarded: 12 Oct 2026
Contract start: 12 Oct 2026
Contract end: 25 Oct 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Região de Coimbra
Source: Original notice on TED (746443-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
RISDIPLAM 5 MG COMP	Unidade Local de Saúde de Coimbra, EPE	ROCHE Farmacêutica Química, LDA	€741,405	27 Oct 2026
Pemigatinib 13.5 mg Comp	Unidade Local de Saúde de Coimbra, EPE	Cencora 3Pl Portugal, S.A.	€136,627	26 Oct 2026
Tocilizumab 20 mg/ml Sol inj Fr 4 ml IV	Unidade Local de Saúde de Coimbra, EPE	ROCHE Farmacêutica Química, LDA	—	26 Oct 2026
Tocilizumab 162 mg/0.9 ml Sol inj Caneta 0.9 ml SC	Unidade Local de Saúde de Coimbra, EPE	ROCHE Farmacêutica Química, LDA	€473,664	26 Oct 2026
ZANUBRUTINIB 160 MG COMP	Unidade Local de Saúde de Coimbra, EPE	Cencora 3Pl Portugal, S.A.	€454,109	23 Oct 2026
VELMANASE ALFA 10 MG PÓ SOL INJ FR IV	Unidade Local de Saúde de Coimbra, EPE	Celltrion Portugal, Unipessoal Lda	€334,768	23 Oct 2026